NCT/Study#

NCT04083976 /

42756493CAN2002

A Phase 2 Study of Erdafitinib in Subjects with Advanced Solid Tumors and Selected FGFR Gene Alterations.

A Phase 2 Study of Erdafitinib in Subjects with Advanced Solid Tumors and Selected FGFR Gene Alterations.

DISEASE GROUP:
Phase 1
current phase:
Phase II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: